CPMS-improving patient care in Europe via virtual case discussions.
Clinical Patient Management System (CPMS)
European Reference Network on Rare Endocrine Conditions (Endo-ERN)
Health care inequalities
Virtual consultation
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
01
11
2020
accepted:
09
01
2021
pubmed:
3
2
2021
medline:
9
7
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
The core task of European Reference Networks (ERNs) is to reduce health care inequalities throughout Europe for all patients with rare and complex conditions. A secure web-based application for virtual consultations, the Clinical Patient Management System (CPMS), was developed by the EU to provide expert specialized care for all these patients. This review analyses the opportunities and difficulties that the implementation of this virtual network implies for physicians as well as for the patients. European Reference Network on Rare Endocrine Conditions (Endo-ERN) installed an Operational Helpdesk (OH) to support their members in using CPMS. The OH initiated several actions to facilitate and increase the usage of CPMS. Satisfaction with the system and reasons for low participation rates in virtual case discussions were analyzed by different surveys. The number of CPMS users increased constantly, but the active usage of the system remains insufficient. Main reasons were technical difficulties, lack of time and insufficient awareness about CPMS in experts and patients throughout Europe. Still, outcomes of the virtual discussions are considered useful by involved experts and the discussions have provided topics for educational webinars and research. CPMS is a secure system with many advantages compared to previous ways of consulting experts but also difficulties that need to be overcome with future strategies. By facilitating its use and increasing awareness among all relevant European experts and patients, CPMS can help to make the existing expertise available for all patients with rare (endocrine) conditions throughout Europe as it was intended.
Identifiants
pubmed: 33528763
doi: 10.1007/s12020-021-02628-x
pii: 10.1007/s12020-021-02628-x
pmc: PMC7851636
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
549-554Références
Endo-ERN: Reference Centres. https://endo-ern.eu/about/reference-centres/ (2020).
Endo-ERN: Overview of specific expertise (MTG). https://endo-ern.eu/specific-expertise/overview-mtg/ (2020).
Endo-ERN: CPMS Informed Consent Forms. https://endo-ern.eu/activities/clinical-activities-ehealth/cpms/cpms-informed-consent-forms/ (2020).
EUR-Lex: COMMISSION IMPLEMENTING DECISION (EU) 2019/1269. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32019D1269 (2019).
European Commission: ERNs and COVID-19. https://ec.europa.eu/health/ern/covid-19_en (2020).
Endo-ERN: Clinical Patient Management System. https://endo-ern.eu/activities/clinical-activities-ehealth/cpms/ (2020).
ERN Collaborative Platform: ERN Status Report September 2020. https://webgate.ec.europa.eu/ern/item/item/18366 (2020).